USPTO serial 98624683
STUDYIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 8, 2025
- Examiner
- FRENCH, CURTIS W
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STUDYIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw Hogan Lovells US LLP555 13th Street NWWashington, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and business management services in the field of clinical trials; management and compilation of computerized databases in the field of clinical trials; providing an internet-based database for business purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries; providing an internet-based database in the field of clinical trials for business purposes featuring business information; business consulting services provided to pharmaceutical industry clients involved in phase i, ii and iii trials | ACTIVE | Nov 1, 2018 |
| 042 | Providing temporary use of non-downloadable software and applications for use in database management and support in connection with clinical trials; medical and scientific research, namely, data analysis in the fields of clinical trials; provision of an internet-based database in the field of medical research for data management; development of customized software for others for use in audit in the nature of electronic approval and audit trail capture in the field of pharmaceutical research and development designed to facilitate complex statistical techniques; programming of computer software for others featuring programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries; providing an internet-based database in the field of medical research for data management; development of customized software for others for use in audit, namely, software for electronic approval and audit trail capture to conduct clinical trials in the field of clinical trials for pharmaceutical research; development design and development of computer software relating to the field of clinical trials; application service provider (asp) featuring software for use in data integration, data analytics, data reporting, database management, and project management; software as a service (saas) services featuring software for managing clinical trials; software as a service (saas) services featuring software for processing, presenting, hosting, managing, and transmitting patient data; software as a service (saas) services featuring software for the editing, organizing, modifying, book marking, transmission, storage and sharing of clinical outcomes assessments; software as a service (saas) services featuring software for enabling users to view, manage and report on patient reported data in pharmaceutical industry clinical trials; software as a service (saas) services featuring software for the development, design, localization and simulation of electronic clinical outcome assessments for pharmaceutical industry clinical trials; consulting services in the design and implementation of computer-based information systems related to clinical trial and supply management for businesses; software as a service (saas) services for computers and mobile devices featuring remote site monitoring software, pharmaceutical industry clinical trial software, data analytics and reporting software, clinical trial patient monitoring software, clinical trial management software, and data integration and transmission software | ACTIVE | Nov 1, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Signant Health Global LLC
- Other trademarks owned by Signant Health Global LLC
- Other trademarks owned by Signant Health Global LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named STUDYIQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 8, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 20, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 20, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 14, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 2, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2024 | NWAP | NEW APPLICATION ENTERED | — |